Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Indian J Med Sci ; 1998 Jun; 52(6): 244-7
Artículo en Inglés | IMSEAR | ID: sea-68661

RESUMEN

40 cases postmenopausal women with breast cancer constituted the study group and 20 sex and age matched formed the control group. The study group of untreated patients showed nonsignificant decrease in molybdenum but significant decrease in blood xanthine oxidase and riboflavin levels. Tamoxifen treated patients showed nonsignificant increase in molybdenum, after 3 months, significant increase after 6 months and significant increase in xanthine oxidase and riboflavin levels. Thus tamoxifen when given in breast cancer helps in amelioration of the diseased condition.


Asunto(s)
Antineoplásicos Hormonales/uso terapéutico , Neoplasias de la Mama/sangre , Femenino , Humanos , Persona de Mediana Edad , Molibdeno/sangre , Posmenopausia , Riboflavina/sangre , Tamoxifeno/uso terapéutico , Xantina Oxidasa/sangre
2.
Indian J Med Sci ; 1998 Apr; 52(4): 143-6
Artículo en Inglés | IMSEAR | ID: sea-66629

RESUMEN

Dried extract of C Indica in doses of 500 mgm/kg body weight were administered orally to 30 diabetic patients for six weeks. Blood samples were collected 15 minutes after administration of 10 IU heparin for estimation of LPL, before and after treatment with C. Indica Non heparinised samples were utilized for estimation for G-6-p (ase), LDH and blood sugar. Severity of disease were assessed by the findings of blood sugar level. Mild diabetes had no effect on LPL, LDH and G-6-P (ase). But, reduced activity of enzyme LPL and raised level of G-6-P (ase) and LDH in plasma of severe diabetics were found to be highly significant (p < 0.001). The alteration in these parameters in untreated diabetics were restored after treatment with C. indica Hence, it can be postulated that the ingredients present in the extract of C. indica, act like insulin, correcting the elevated enzymes G-6-p (ase), LDH in glycolytic pathway and restore the LPL activity in lypolytic pathway with the control of hyperglycemia in diabetes.


Asunto(s)
Diabetes Mellitus/diagnóstico , Femenino , Glucosa-6-Fosfatasa/metabolismo , Glucólisis/efectos de los fármacos , Humanos , L-Lactato Deshidrogenasa/efectos de los fármacos , Lipólisis/efectos de los fármacos , Lipoproteína Lipasa/efectos de los fármacos , Masculino , Extractos Vegetales/uso terapéutico , Valores de Referencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA